catechin has been researched along with Nervous System Diseases in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (75.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alemi, F; Karimian, A; Majidinia, M; Safa, A; Yousefi, B | 1 |
| Cao, M; Fang, F; Zhang, S | 1 |
| Almeida-Toledano, L; Andreu-Fernández, V; Garcia-Algar, O; Navarro-Tapia, E; Sailer, S; Sebastiani, G; Serra-Delgado, M; Valverde, O | 1 |
| Cai, F; Li, C; Lin, F; Ma, S; Min, Q; Ouyang, C; Wu, J; Yu, W; Zheng, M | 1 |
3 review(s) available for catechin and Nervous System Diseases
| Article | Year |
|---|---|
Targeting miRNAs by polyphenols: Novel therapeutic strategy for aging.
Topics: Aging; Cardiovascular Diseases; Catechin; Gene Expression Regulation; Humans; Longevity; MicroRNAs; Neoplasms; Nervous System Diseases; Polyphenols | 2020 |
The Role of Epigallocatechin-3-Gallate in Autophagy and Endoplasmic Reticulum Stress (ERS)-Induced Apoptosis of Human Diseases.
Topics: Apoptosis; Autophagy; Cardiovascular Diseases; Catechin; Diabetes Mellitus; Endoplasmic Reticulum Chaperone BiP; Endoplasmic Reticulum Stress; Humans; Neoplasms; Nervous System Diseases; Signal Transduction | 2020 |
Therapeutic Effects of Catechins in Less Common Neurological and Neurodegenerative Disorders.
Topics: Adult; Aged; Aged, 80 and over; Animals; Antioxidants; Catechin; Cognitive Aging; Female; Humans; Male; Middle Aged; Nervous System Diseases; Neurodegenerative Diseases; Neuronal Plasticity; Neuroprotective Agents | 2021 |
1 other study(ies) available for catechin and Nervous System Diseases
| Article | Year |
|---|---|
Modulation of the oxidative stress and nuclear factor kappaB activation by theaflavin 3,3'-gallate in the rats exposed to cerebral ischemia-reperfusion.
Topics: Animals; Biflavonoids; Brain; Brain Ischemia; Catechin; Cell Extracts; Cerebral Infarction; Cyclooxygenase 2; Gallic Acid; Gene Expression Regulation, Enzymologic; Glutathione Peroxidase; I-kappa B Proteins; Lipid Peroxidation; Malondialdehyde; Nervous System Diseases; NF-kappa B; NF-KappaB Inhibitor alpha; Nitric Oxide; Nitric Oxide Synthase Type II; Oxidative Stress; Rats; Reperfusion Injury; Superoxide Dismutase | 2007 |